You are here

  • Home
  • Archive
  • Volume 57, Issue 1
  • β2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells

Article Text

Article menu
Download PDFPDF
Original articles
β2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells
  1. B Lipworth1,
  2. G H Koppelman3,
  3. A P Wheatley2,
  4. I Le Jeune2,
  5. W Coutie1,
  6. H Meurs4,
  7. H F Kauffman5,
  8. D S Postma3,
  9. I P Hall2
  1. 1Asthma and Allergy Research Group, Clinical Pharmacology and Therapeutics, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK
  2. 2Division of Therapeutics, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK
  3. 3Department of Pulmonology, University Hospital Groningen, Groningen, the Netherlands
  4. 4Department of Molecular Pharmacology, University Centre for Pharmacy, Groningen
  5. 5Department of Allergology, University Hospital Groningen
  1. Correspondence to:
    Professor I P Hall, Division of Therapeutics, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK;
    Ian.hall{at}nottingham.ac.uk

Abstract

Background: The β2 adrenoceptor and its 5′ untranslated region contain a number of genetic variants. The aim of this study was to investigate the potential for genetic variation at this locus to influence the expression of β2 adrenoceptors on circulating peripheral blood mononuclear cells (PBMCs).

Methods: Genotype was determined in 96 individuals with asthma for four polymorphisms at the β2 adrenoceptor locus. β2 adrenoceptor binding and cyclic AMP responses to isoprenaline in PBMCs were determined and the relationship between genotype/haplotype and β2 adrenoceptor expression and response to isoprenaline examined.

Results: β2 adrenoceptor promoter polymorphisms were found to be common in white subjects. Strong linkage disequilibrium exists across this locus, resulting in the occurrence of several common haplotypes. No single polymorphism or haplotype was correlated with the level of β2 adrenoceptor expression or cyclic AMP responses to isoprenaline in vitro.

Conclusion: β2 adrenoceptor polymorphisms, when considered in isolation or by extended haplotypes, do not determine the basal level of expression or coupling of β2 adrenoceptors in PBMCs from asthmatic subjects.

  • β2 adrenoceptor
  • polymorphism
  • haplotype
  • asthma
  • pharmacogenetics

https://doi.org/10.1136/thorax.57.1.61

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • BL, GHK and APW contributed equally to the work described in this paper.